To the central content area :::

TPEx

Listed Companies

:::
:::Listed Companies > Listed Companies Info. > Emerging Stock Board Companies > Listed Company Profile

ESM Companies

For foreign Emerging Stock Board enterprises, ”*- country of incorporation” indicates stocks without par value or with par value other than NT$10, and ”- country of incorporation” indicates stocks with par value of NT$10 per share.
6945 APBio
中文
Basic information
Chairman President Spokesperson Telephone Address ESM Registration Date
Chen,Chi-Chuan Her, Jeng-Horng Her, Jeng-Horng 02-26532886 11F-2,No508,Sec7,Zhongxao E RdTaipei, Taiwan 2023/07/14
Industry
category
Key businesses
Biotechnology and Medical Care Over the last 20 years, the growth of biotherapeutic antibodies, has had a dramatic impact on many areas of medicine, including infectious, immune-mediated, and respiratory diseases, as well as hematology and oncology. APBio is currently developing fully-human,mono- and bi-specific antibodies with novel mechanisms of action to fulfill unmet medical needs. Combining our integrated protein engineering and antibody technology, we have produced a portfolio of biotherapeutic leads & bi-specific antibodies to treat serious medical conditions with a primary clinical focus on oncology. With mechanism-based drug design focusing on disease-specific targets, we are aiming to provide patients with medicines that are safe, efficacious and cost-effective. We believe that the biotherapeutics developed this way will offer important clinical and economic advantages, making these protein drugs better choices for the patients.
 
Market info
Latest trading info Historic trading info
 
Financial data
Cash flows statement Item
Amount(NTD, in thousands)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Consolidated/Individual
balance sheet
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Consolidated/Individual
profit and loss
statement
Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Profit
Other comprehensive income
Comprehensive income
Basic earnings per share
 Auditor's report on latest financial statements: auditor's report:
 Investors may find more detailed information on the company by visiting the Market Observation Post System.。
 The information disclosed here concerning foreign enterprises consists of amounts provided in consolidated financial statements.